Stimulation test in the follow-up of thyroid cancer: Plasma rhTSH levels are dependent on body weight, not endogenously stimulated TSH values

Paolo Zanotti-Fregonara, Françoise Duron, Isabelle Keller, Alexandre Khoury, Jean Yves Devaux, Elif Hindié

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Stimulation testing in the first year following thyroid ablation has important prognostic value in thyroid cancer patients. Recombinant human TSH (rhTSH) is better tolerated than thyroid hormone withdrawal but provides only transient stimulation so that the TSH threshold of 30舁mIU·l−1 which defines adequate testing during thyroid hormone withdrawal is not appropriate for rhTSH stimulation. We looked at rhTSH levels after a standard two intramuscular injections of 0.9舁mg rhTSH.

Original languageEnglish (US)
Pages (from-to)257-259
Number of pages3
JournalNuclear medicine communications
Volume28
Issue number4
DOIs
StatePublished - Jan 1 2007

Keywords

  • Body weight
  • RhTSH
  • TSH plasma levels

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Stimulation test in the follow-up of thyroid cancer: Plasma rhTSH levels are dependent on body weight, not endogenously stimulated TSH values'. Together they form a unique fingerprint.

Cite this